David Byrd
Overview
Explore the profile of David Byrd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
973
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Applying Positive Psychology to the L2 Classroom: Acknowledging and Fostering Emotions in L2 Writing
Byrd D, Abrams Z
Front Psychol
. 2022 Aug;
13:925130.
PMID: 35992446
The process of learning a new language can be filled with many emotions, both positive and negative, for the learner. This is particularly true in the area of writing, where...
2.
Byrd G, Custovic S, Byrd D, Miano D, Bathla J, Attallah A
Case Rep Crit Care
. 2021 Jul;
2021:8817067.
PMID: 34327026
Background: Eptifibatide is a glycoprotein IIb/IIIa (GP IIb/IIIa) receptor inhibitor which prevents platelet activation. The mechanism in which eptifibatide causes profound thrombocytopenia is poorly understood. One hypothesis suggests antibody-dependent pathways...
3.
Gastman B, Agarwal P, Berger A, Boland G, Broderick S, Butterfield L, et al.
J Immunother Cancer
. 2020 Nov;
8(2).
PMID: 33199512
Immunotherapy is now a cornerstone for cancer treatment, and much attention has been placed on the identification of prognostic and predictive biomarkers. The success of biomarker development is dependent on...
4.
Singh N, Alexander N, Lachance K, Lewis C, McEvoy A, Akaike G, et al.
J Am Acad Dermatol
. 2020 Jul;
84(2):330-339.
PMID: 32707254
Background: Merkel cell carcinoma (MCC) guidelines derive from melanoma and do not recommend baseline cross-sectional imaging for most patients. However, MCC is more likely to have metastasized at diagnosis than...
5.
Sickora C, Salt R, Page T, Lee W, Cantu A, Lee M, et al.
J Nurs Educ
. 2020 Jan;
59(1):30-33.
PMID: 31945172
Background: Natural disasters, such as Hurricane Harvey, can provide unique hands-on learning experiences for nursing students. Method: The University of Texas Health Science Center at San Antonio School of Nursing...
6.
Brierley J, OSullivan B, Asamura H, Byrd D, Huang S, Lee A, et al.
Nat Rev Clin Oncol
. 2019 Aug;
16(12):763-771.
PMID: 31388125
Disease burden is the most important determinant of survival in patients with cancer. This domain, reflected by the cancer stage and codified using the tumour-node-metastasis (TNM) classification, is a fundamental...
7.
Haddad R, Nasr C, Bischoff L, Busaidy N, Byrd D, Callender G, et al.
J Natl Compr Canc Netw
. 2018 Dec;
16(12):1429-1440.
PMID: 30545990
The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the management of different types of thyroid carcinoma, including papillary, follicular, Hürthle cell, medullary, and anaplastic carcinomas. These NCCN Guidelines Insights...
8.
The TNM classification of malignant tumours-towards common understanding and reasonable expectations
OSullivan B, Brierley J, Byrd D, Bosman F, Kehoe S, Kossary C, et al.
Lancet Oncol
. 2017 Jul;
18(7):849-851.
PMID: 28677562
No abstract available.
9.
Boughey J, Ballman K, McCall L, Mittendorf E, Symmans W, Julian T, et al.
Ann Surg
. 2017 Jun;
266(4):667-676.
PMID: 28657941
Background: Women with node-positive breast cancer are at high risk for recurrence. We evaluate the impact of approximated tumor subtype and response to chemotherapy on long-term outcomes in a node-positive...
10.
Bhatia S, Storer B, Iyer J, Moshiri A, Parvathaneni U, Byrd D, et al.
J Natl Cancer Inst
. 2016 Jun;
108(9).
PMID: 27245173
Background: Merkel cell carcinoma (MCC) has a high risk of recurrence after initial surgical therapy. Adjuvant radiation therapy (RT) and chemotherapy may be used to reduce the risk of locoregional...